Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 12 of 12 publications.

Adelakun A, Dolph M, Matthews E, Oglebsy A, Campbell K, Davis A, Xu J, Hardy I, Danchenko N, Anderson SJ. Cost-effectiveness and public-health impact of cabotegravir long-acting injectable for HIV pre-exposure prophylaxis in Canada. Poster presented at the HIV Drug Therapy Glasgow 2024; November 10, 2024. Glasgow, Scotland. [abstract] J Int AIDS Soc. 2024 Nov; 27:234-5.

Montgomery ET, Beksinska M, Mgodi N, Schwartz J, Weinrib R, Browne EN, Mphili N, Musara P, Jaggernath M, Ju S, Smit J, Chirenje ZM, Doncel GF, van der Straten A. End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study. J Int AIDS Soc. 2019 May;22(5):e25283. doi: 10.1002/jia2.25283.

Sussman G, Abuzakouk M, Berard F, Canonica W, Oude Elberink H, Gimenez-Arnau A, Grattan C, Hollis K, Hunter S, Knulst A, Lacour JP, Lynde C, Marsland A, McBride D, Maurer M, Nakonechna A, Ortiz De Frutos J, Reynolds M, Sweeney C, Tian H, Weller K, Wolin D, Balp MM. Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: analyses from ASSURE-CSU. Allergy. 2018 Aug;73(8):1724-34. doi: 10.1111/all.13430

van der Straten A, Agot K, Ahmed K, Weinrib R, Browne EN, Manenzhe K, Owino F, Schwartz J, Minnis A, TRIO Study Team. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention. J Int AIDS Soc. 2018 Mar;21(3):e25094. doi: 10.1002/jia2.25094

Maurer M, Abuzakouk M, Berard F, Canonica W, Oude Elberink H, Gimenez-Arnau A, Grattan C, Hollis K, Knulst A, Lacour JP, Lynde C, Marsland A, McBride D, Nakonechna A, Ortiz De Frutos J, Proctor C, Sussman G, Sweeney C, Tian H, Weller K, Wolin D, Balp M-M. The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU. Allergy. 2017 Dec;27(12):2005-16. doi: 10.1111/all.13209

Maurer M, Weller K, Nakonechna A, Abouzakouk M, Hollis KA, McBride DW, Georgiou P, Balp MM, Grattan C. The first international study assessing the economic and humanistic burden of refractory chronic spontaneous/idiopathic urticaria: aSSURE-CSU. Poster presented at the European Academy of Allergy and Clinical Immunology Congress; August 2014. Copenhagen, Denmark. [abstract] Allergy. 2014 Sep; 69(Suppl 99):122.

Heyes A, Lebiecki J, Serup-Hansen N, Andreasen J. Identification of cost-drivers in the management of patients with allergic rhinitis. Poster presented at the XXXI Congress of the European Academy of Allergy and Clinical Immunology; June 2012. Geneva, Switzerland. [abstract] Allergy. 2012 Nov; 67(S96):344.

Herring WL, Herrmann JW. The single-day surgery scheduling problem: sequential decision-making and threshold-based heuristics. OR spectrum: quantitative approaches in management. 2012 Apr 1;34(2):429-59.

Anto JM, Sunyer J, Basagana X, Garcia‐Esteban R, Cerveri I, de Marco R, Heinrich J, Janson C, Jarvis D, Kogevinas M, Kuenzli N, Leynaert B, Svanes C, Wjst M, Gislason T, Burney P. Risk factors of new-onset asthma in adults: a population-based international cohort study. Allergy. 2010 Aug;65(8):1021-30. doi: 10.1111/j.1398-9995.2009.02301.x

Arellano FM, Arana A, Wentworth CE. Potent topical steroids are the treatment for cutaneous T-cell lymphoma. Allergy. 2010;126(2):414-5.

Philpot E, Prillaman B, Wu W, Toler W. Correlation of patient-rated nasal congestion with peak nasal inspiratory flow assessments in three allergic rhinitis studies of fluticasone furoate nasal spray. Poster presented at the XXVIII EAACI Congress of the European Academy of Allergy and Clinical Immunology; June 2009. Warszawa, Poland. [abstract] Allergy. 2009; 64(S90):37-8.

Sunyer J, Pekkanen J, Garcia-Esteban R, Svanes C, Kunzli N, Janson C, de Marco R, Anto JM, Burney P. Asthma score: predictive ability and risk factors. Allergy. 2007 Feb;62(2):142-8. doi: 10.1111/j.1398-9995.2006.01184.x